Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Clasificación en acciones #28154
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Precio por acción
$1.40
Última sincronización: 2026-08-18
Capitalización bursátil
$28.25M
Cambio (1 día)
0.00%
Cambio (1 año)
536.36%
País
IL
Comercio Raphael Pharmaceutical Inc. (RAPH)

Categoría

Ratio P/B de Raphael Pharmaceutical Inc. (RAPH)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Raphael Pharmaceutical Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Raphael Pharmaceutical Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras